U.S. Markets closed

Iliad SA (ILD.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
230.50-0.70 (-0.30%)
At close: 5:35PM CEST
Interactive chart
Previous Close231.20
Bid183.10 x 600
Ask187.50 x 2500
Day's Range228.60 - 230.50
52 Week Range166.70 - 236.70
Avg. Volume110,862
Market Cap13.54B
PE Ratio (TTM)34.56
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The Wall Street Journal21 days ago

    [$$] Jury Awards $110 Million to Plaintiff in Johnson & Johnson Baby Powder Case

    Johnson & Johnson was hit with a $110 million jury decision in favor of a woman who said talc in the company’s baby powder gave her ovarian cancer, the latest—and largest—verdict yet in the litigation ...

  • J&J Loses $110 Million Verdict Over Talc Cancer-Link Claim
    Bloomberg23 days ago

    J&J Loses $110 Million Verdict Over Talc Cancer-Link Claim

    Johnson & Johnson was ordered by a St. Louis jury to pay more than $110 million to a Virginia woman who blamed her ovarian cancer on the company’s talcum products.

  • Reuters3 months ago

    Altice mum on possible US listing as quarterly profits rise

    Altice, the fourth-biggest cable operator in the United States, reported a 16 percent jump in quarterly core operating profit on Wednesday but gave no update on whether it might list its U.S. business. The group's founder, Franco-Israeli tycoon Patrick Drahi, has expanded through a rapid series of debt-fuelled acquisitions in the United States and Europe that has left it with total net debt of 50.4 billion euros ($53 bln) at the end of 2016, or about twice its annual revenues. The group's operating free cash flow, however, jumped 20.4 percent to 968 million euros in the fourth quarter, potentially giving it room to pay down some of that debt.